ENTRY       D10535                      Drug
NAME        Meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated;
            Menactra (TN);
            Nimenrix (TN)
PRODUCT     MENVEO (GlaxoSmithKline Biologicals SA)
REMARK      Therapeutic category: 6311
            ATC code: J07AH08
            Product: D10535<JP/US>
EFFICACY    Active immunization (pneumococcal)
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             J ANTIINFECTIVES FOR SYSTEMIC USE
              J07 VACCINES
               J07A BACTERIAL VACCINES
                J07AH Meningococcal vaccines
                 J07AH08 Meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated
                  D10535  Meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Immunological Agents
              Vaccines
               Meningococcal
                Meningococcal Polysaccharide (Groups A, C, Y and W-135) Diphtheria Toxoid Conjugate Vaccine (MCV4P)
                 D10535  Meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated
            Therapeutic category of drugs in Japan [BR:br08301]
             6  Agents against pathologic organisms and parasites
              63  Biological preparations
               631  Vaccines
                6311  Bacterial vaccines
                 D10535  Meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10535
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D10535
DBLINKS     PubChem: 254741497
///
